Sliding Scale Regular Human Insulin for Identifying Critically Ill Patients Who Require Intensive Insulin Therapy and for Glycemic Control in those with Mild to Moderate Hyperglycemia
العنوان: | Sliding Scale Regular Human Insulin for Identifying Critically Ill Patients Who Require Intensive Insulin Therapy and for Glycemic Control in those with Mild to Moderate Hyperglycemia |
---|---|
المؤلفون: | Gayle Minard, Susan E. Smith, Sarah V. Cogle, Roland N. Dickerson, George O. Maish, Martin A. Croce |
المصدر: | Journal of Pharmacy and Nutrition Sciences. 7:106-115 |
بيانات النشر: | Set Publishers, 2017. |
سنة النشر: | 2017 |
مصطلحات موضوعية: | 0301 basic medicine, medicine.medical_specialty, 030109 nutrition & dietetics, Nutrition and Dietetics, Health (social science), business.industry, Critically ill, Insulin, medicine.medical_treatment, Medicine (miscellaneous), 030209 endocrinology & metabolism, Hypoglycemia, medicine.disease, Surgery, Sliding scale, 03 medical and health sciences, Glycemic management, 0302 clinical medicine, Parenteral nutrition, Anesthesia, Human insulin, Medicine, General Pharmacology, Toxicology and Pharmaceutics, business, Glycemic |
الوصف: | Two sliding scale regular human insulin (RHI) algorithms (SSI) were retrospectively evaluated to identify those who develop severe hyperglycemia (blood glucose (BG) > 180 mg/dL) and for glycemic management of continuously-fed, critically ill trauma patients with mild to moderate hyperglycemia (BG 126 to 179 mg/dL). Assignment of low or high SSI was based upon anticipated severity of difficulty in glycemic control. BG was obtained every 3 to 6 hours. Target BG range was 70 to 149 mg/dL. Patients who were unable to achieve a BG < 150 mg/dL with SSI and who required a continuous intravenous RHI infusion were identified. Twenty-five of 121 patients (21%) failed SSI necessitating more intensive insulin therapy. The low and high intensity SSI groups exhibited a baseline BG of 123 + 33 mg/dL and 164 + 20 mg/dL (P = 0.001). Average BG for each group was 129 ± 14 mg/dL and 145 ± 21 mg/dL (P = 0.001). Each group spent 20 ± 4 and 16 ± 5 hours/day within the target BG range (P = 0.001), respectively. Mild hypoglycemia (BG 40 - 60 mg/dL) occurred in 11% and 7% of patients from each group (P = N.S.). Severe hypoglycemia (BG < 40 mg/dL) occurred in zero and two (5%) patients, respectively (P = N.S). SSI served as a useful technique to identify those requiring more intensive insulin therapy and was safe and efficacious for continuously-fed, critically ill trauma patients with mild to moderate hyperglycemia. |
تدمد: | 1927-5951 2223-3806 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::cb88501bde9b11dbab5ea670a1972f00Test https://doi.org/10.6000/1927-5951.2017.07.03.6Test |
حقوق: | OPEN |
رقم الانضمام: | edsair.doi...........cb88501bde9b11dbab5ea670a1972f00 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 19275951 22233806 |
---|